Home » Applied Announces Clearance for Breast Cancer Assessment Test
Applied Announces Clearance for Breast Cancer Assessment Test
May 11, 2005
Applied Imaging announced it has received 510(k) clearance from the FDA to market its Ariol Her-2/neu FISH application, which is designed to detect Her-2/neu gene amplification in breast cancer biopsy samples via fluorescence in situ hybridization (FISH).
Yahoo News (http://biz.yahoo.com/prnews/050510/latu055.html?.v=9)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct